[Surveys on side effects of drugs].
Explore the source record for details and available documents.
Drug Hypersensitivity↗
Biomedical subjects
J L Schelling
Publications and source records attributed to J L Schelling.
Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation.
Explore the source record for details and available documents.
Adrenergic beta-Antagonists↗
[Blood circulation and venous distensibility in the forearm].
Explore the source record for details and available documents.
Dilatation↗
[Drugs prescribed in cerebrovascular disorders].
Explore the source record for details and available documents.
Anticholesteremic Agents↗
[Placebos and double-blind studies: significant differences].
Explore the source record for details and available documents.
Clinical Trials as Topic↗
[Controlled study of 3 sulfonamides in chronic urinary and bronchial infections].
Explore the source record for details and available documents.
Aged↗
[Drug effectiveness and abuse].
Explore the source record for details and available documents.
Amphetamine↗
[Glucose tolerance and insulinemia in obese patients treated with hydrochlorothiazide].
Explore the source record for details and available documents.
Adult↗
Limb blood flow in patients and carriers of Duchenne muscular dystrophy.
Explore the source record for details and available documents.
Blood Flow Velocity↗
A study of cross-tolerance to circulatory effects of organic nitrates.
Explore the source record for details and available documents.
Adult↗
Effect of pindolol, a beta receptor antagonist, in hyperthyroidism.
Explore the source record for details and available documents.
Adult↗
Intravenous glycerol in cerebral infarction: a controlled 4-month trial.
A double-blind, randomized trial was performed with 51 patients suffering from focal ischemic lesions in the territory of the middle cerebral artery. Intravenous infusions of 10% glycerol in 0.9% NaCl--5% glucose solutions were administered twice daily for 6 days to 26 patients, and the same amount of NaCl--glucose solutions to 25 controls. Glycerol did not reduce mortality (9 deaths in each group). The functional recovery was assessed by repeated neurological examinations during the 4 month trial. Glycerol significantly improved global performances and motor and sensory functions in patients with moderate disability, but its effect on global performances was transient. The patients with severe disability were not improved at all.
Aged↗